Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review, AIDS, vol.20, pp.2165-2174, 2006. ,
Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system, J Clin Endocrinol Metab, vol.93, pp.3499-3504, 2008. ,
HIV Infection Is Strongly Associated With Hip Fracture Risk, Independently of Age, Gender, and Comorbidities:A Population-Based Cohort Study, J. Bone Miner. Res, vol.28, pp.1259-1263, 2013. ,
HIV Infection and Its Association With an Excess Risk of Clinical Fractures: A Nationwide Case-Control Study, JAIDS, vol.66, pp.90-95, 2014. ,
Increased risk of fragility fractures among HIV-infected compared to uninfected male veterans, PloS One, vol.6, p.17217, 2011. ,
Increased rates of bone fracture among HIVinfected persons in the HIV Outpatient Study (HOPS) compared with the US general population, Clin Infect Dis, vol.52, pp.1061-1068, 2006. ,
increased fracture incidence in middle-aged HIV-infected and uninfected women: updated results from the Women's Interagency HIV Study, JAIDS, vol.70, pp.54-61, 2015. ,
Continous antiretroviral therapy decreases bone mineral density, AIDS, vol.23, pp.1519-1529, 2009. ,
Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from randomized trial, HIV Med, vol.12, pp.157-165, 2011. ,
Bone mineral density and fracture in antiretroviral-naïve persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202, J Infect Dis, vol.203, pp.1791-1801, 2011. ,
Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study, Clin Infect Dis, vol.51, pp.963-972, 2010. ,
Greater decrease in bone mineral density with protease inhibitor regimens compared with non nucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naïve patients, AIDS, vol.23, pp.817-824, 2009. ,
Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study, BMC infection, vol.2013, p.293 ,
URL : https://hal.archives-ouvertes.fr/inserm-00843065
Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT, J Bone Miner Res, vol.27, pp.119-143, 2012. ,
Bone mineral density in HIV-negative men participating ,